BetterLife Pharma Inc. Total Assets

• BetterLife Pharma Inc. showed a decrease of -30.7% in Total Assets from 2024 to 2025.
• This data is from BetterLife Pharma Inc.'s annual report (Form 10-K), filed with the SEC on June 2, 2025.
• XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2011: $7.4 thousand | Q2 2012: $7.1 thousand | Q3 2012: $6.7 thousand | Q4 2012: $6.6 thousand | Q2 2013: $20.6 thousand | Q3 2013: $6.8 thousand | Q4 2013: $14.3 thousand | Q2 2014: $6.7 thousand | Q3 2014: $11.5 thousand | Q4 2014: $7.9 thousand | Q2 2015: $35.0 thousand | Q3 2015: $271.8 thousand | Q4 2015: $208.2 thousand | Q2 2016: $54.9 thousand | Q4 2016: $228.7 thousand | Q2 2017: $66.4 thousand | Q3 2017: $36.0 thousand | Q4 2017: $535.2 thousand | Q2 2018: $8.81 million | Q3 2018: $7.59 million | Q4 2018: $7.08 million | Q1 2019: $8.60 million | Q2 2019: $9.55 million.
• Over the full 15 years of available data (2011 to 2025), BetterLife Pharma Inc.'s Total Assets has grown by 1,202.2%.
• Historical annual values: Fiscal year 2025: $225.0 thousand | Fiscal year 2024: $324.7 thousand | Fiscal year 2023: $74.7 thousand | Fiscal year 2022: $1.16 million | Fiscal year 2021: $1.34 million | Fiscal year 2019: $8.60 million | Fiscal year 2018: $471.8 thousand | Fiscal year 2017: $132.7 thousand | Fiscal year 2016: $106.1 thousand | Fiscal year 2015: $1.3 thousand | Fiscal year 2014: $7.2 thousand | Fiscal year 2013: $6.1 thousand | Fiscal year 2012: $3.8 thousand | Fiscal year 2011: $3.8 thousand | Fiscal year 2011: $17.3 thousand.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026